Program Agenda
2023 LEAD Email Banner _v2 (960 × 180 px)

New for 2023, the American Headache Society announces the Leadership in Advocacy Development (LEAD) Program, which aims to provide training, tools, mentorship, and support for mid-career healthcare professionals and physician advocacy leaders in headache medicine.

Participants will explore new opportunities for professional development through formal didactic sessions and small group workshops with leaders in the field on topics including practice management, advocacy, and project management, as well as the development of an advocacy project over a 2-year longitudinal timeframe.


The AHS actively monitors the health and safety guidance from the Centers for Disease Control as well as state and local health departments. We want attendees to enjoy a safe environment at all AHS meetings. While the AHS continues to recommend people are up to date on COVID-19 vaccination, attendees of AHS meetings are not required to be vaccinated or verify vaccination status. In addition, masks are optional for AHS meetings and prior antigen testing is not required. We will continue to follow best practices recommended by the Centers for Disease Control and Prevention and abide by any legal mandates and recommendations from government officials in the location of any AHS meeting. These protocols and information are subject to change.

Please note, even with safeguards and the AHS’s overarching commitment to attendee wellness, there remains a risk of contracting COVID-19.

Program Committee

Amaal Starling, MD, MS, FAHS
Mayo Clinic
Scottsdale, Arizona

Jessica Ailani, MD, FAHS
MedStar Georgetown University Hospital
Washington, District of Columbia
Maureen A. Moriarty, APRN, DNP, FAH
Moriarty Associates
Westminster, Maryland
Olivia Begasse de Dhaem, MD, FAHS
Hartford Healthcare
Westport, Connecticut
Barbara Nye
Wake Forest Baptist Health Center
Winston Salem, North Carolina
Larry Charleston IV, MD, MS, FAHS
Michigan State University College of Human Medicine
East Lansing, Michigan
Matthew S. Robbins, MD, FAHS
Weill Cornell Medicine
New York, New York
Christopher H. Gottschalk, MD, FAHS
Yale Neurology Group
New Haven, Connecticut
Robert E. Shapiro
University of Vermont
Burlington, Vermont
Teshamae Monteith, MD, FAHS
University of Miami School of Medicine
Miami, Florida
2023 LEAD Email Banner _v2 (960 × 180 px)

Please check back soon for a formal agenda!

Development topics will consist of the following:

  • Practice Management including coding, regulatory requirements, reimbursement, and healthcare delivery models with the goal of enhancing patient care and improving the practice of headache medicine
  • Engagement with the patient advocacy community
  • Legislative advocacy
  • DEI faculty-led discussions with a focus on closing healthcare disparities
  • Traditional and social media training with the goal of enhancing message amplification and brand building
  • Project management training including how to identify, focus the scope, plan, and implement a project
  • 1:1 mentorship for the development and execution of a proposed advocacy project
2023 LEAD Email Banner _v2 (960 × 180 px)

The 2023 Leadership in Advocacy Development (LEAD) Program will take place in conjunction with the 2023 Scottsdale Headache Symposium®, November 15-19, 2023, and 2024 Headache on the Hill, March 18-19, 2024.

Participants will receive complimentary registration and expenses paid for the 2023 Scottsdale Headache Symposium and 2024 Headache on the Hill events.

Candidate Criteria

  • Must be an AHS member in good standing for at least 3 years
  • Must be 7+ years in clinical practice
  • Must have a strong interest in practice management and/or advocacy
  • Must commit to attending the 2023 Scottsdale Headache Symposium and 2024 Headache on the Hill events in person (expenses paid)
  • Must commit to the development and completion of a proposed advocacy project over a 2-year longitudinal timeframe

Application and Supporting Materials

Applicants must complete the online application form and provide the following supporting materials:

  • CV
  • Letter of support speaking to the leadership potential and interest in advocacy of the applicant
  • Personal statement up to 500 words. Questions to consider:
    • What has motivated you to apply?
    • What would you like to accomplish as an advocate?
    • As a busy professional, how will you make time to pursue your advocacy project? How many hours per month can you dedicate?
  • Health professional/physician advocacy project proposal up to 500 words describing your major goal/vision for the 2-year longitudinal program and your desired outcome. Questions to consider:
    • What are you trying to do? What health problem are you trying to solve?
    • How does this get done at present and what are the current challenges?
    • What is novel about your approach? Why do you think you can be successful at this time?

Application Timeline:

  • Wednesday, July 19: Applications open
  • Sunday, August 27: Applications due
  • On or about Monday, September 18: Final decisions to be distributed